CBIO stock forecast
Our latest prediction for Catalyst Biosciences, Inc.'s stock price was made on the Aug. 10, 2020 when the stock price was at 5.66$.
In the short term (2weeks), CBIO's stock price should underperform the market by -1.56%. During that period the price should oscillate between -10.25% and +13.21%.
In the medium term (3months), CBIO's stock price should underperform the market by -7.59%. During that period the price should oscillate between -40.49% and +29.82%.Get email alerts
Create a solid portfolio with CBIO
About Catalyst Biosciences, Inc.
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.
At the moment the company generates 18M USD in revenues.
On its last earning announcement, the company reported a loss of -3.50$ per share.
The book value per share is 11.47$
Three months stock forecastAug. 10, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|